Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Chan, Arlene, Prof, Delaloge, Suzette, MD, Holmes, Frankie A, MD, Moy, Beverly, MD, Iwata, Hiroji, MD, Harvey, Vernon J, MD, Robert, Nicholas J, MD, Silovski, Tajana, MD, Gokmen, Erhan, MD, von Minckwitz, Gunter, Prof, Ejlertsen, Bent, MD, Chia, Stephen K L, MD, Mansi, Janine, MD, Barrios, Carlos H, Prof, Gnant, Michael, Prof, Buyse, Marc, ScD, Gore, Ira, MD, Smith, John, MD, Harker, Graydon, MD, Masuda, Norikazu, MD, Petrakova, Katarina, MD, Zotano, Angel Guerrero, MD, Iannotti, Nicholas, MD, Rodriguez, Gladys, MD, Tassone, Pierfrancesco, Prof, Wong, Alvin, PharmD, Bryce, Richard, MBChB, Ye, Yining, PhD, Yao, Bin, MS, Martin, Miguel, Prof
Published in The lancet oncology (01.03.2016)
Published in The lancet oncology (01.03.2016)
Get full text
Journal Article
Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer
STOCKLER, Martin R, HARVEY, Vernon J, CORONA GAINFORD, M, FONG, Akiko, PAKSEC, Lisa, SOURJINA, Tatiana, ZANNINO, Diana, GEBSKI, Val, JOHN SIMES, R, FORBES, John F, COATES, Alan S, FRANCIS, Prudence A, BYRNE, Michael J, ACKLAND, Stephen P, FITZHARRIS, Bernie, VAN HAZEL, Guy, WILCKEN, Nicholas R. C, GRIMISON, Peter S, NOWAK, Anna K
Published in Journal of clinical oncology (01.12.2011)
Published in Journal of clinical oncology (01.12.2011)
Get full text
Journal Article
Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial
Grimison, Peter S., Stockler, Martin R., Thomson, Damien B., Olver, Ian N., Harvey, Vernon J., Gebski, Val J., Lewis, Craig R., Levi, John A., Boyer, Michael J., Gurney, Howard, Craft, Paul, Boland, Amy L., Simes, R. John, Toner, Guy C.
Published in JNCI : Journal of the National Cancer Institute (18.08.2010)
Published in JNCI : Journal of the National Cancer Institute (18.08.2010)
Get full text
Journal Article
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial
Ruhstaller, Thomas, Giobbie-Hurder, Anita, Colleoni, Marco, Jensen, Maj-Britt, Ejlertsen, Bent, de Azambuja, Evandro, Neven, Patrick, Láng, István, Jakobsen, Erik Hugger, Gladieff, Laurence, Bonnefoi, Hervé, Harvey, Vernon J, Spazzapan, Simon, Tondini, Carlo, Del Mastro, Lucia, Veyret, Corinne, Simoncini, Edda, Gianni, Lorenzo, Rochlitz, Christoph, Kralidis, Elena, Zaman, Khalil, Jassem, Jacek, Piccart-Gebhart, Martine, Di Leo, Angelo, Gelber, Richard D, Coates, Alan S, Goldhirsch, Aron, Thürlimann, Beat, Regan, Meredith M
Published in Journal of clinical oncology (10.01.2019)
Published in Journal of clinical oncology (10.01.2019)
Get full text
Journal Article
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial
Joensuu, Heikki, Fraser, Judith, Wildiers, Hans, Huovinen, Riikka, Auvinen, Päivi, Utriainen, Meri, Nyandoto, Paul, Villman, Kenneth K, Halonen, Päivi, Granstam-Björneklett, Helena, Lundgren, Lotta, Sailas, Liisa, Turpeenniemi-Hujanen, Taina, Tanner, Minna, Yachnin, Jeffrey, Ritchie, Diana, Johansson, Oskar, Huttunen, Teppo, Neven, Patrick, Canney, Peter, Harvey, Vernon J, Kellokumpu-Lehtinen, Pirkko-Liisa, Lindman, Henrik
Published in JAMA oncology (01.09.2018)
Published in JAMA oncology (01.09.2018)
Get more information
Journal Article
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy
Ribi, Karin, Luo, Weixiu, Walley, Barbara A., Burstein, Harold J., Chirgwin, Jacquie, Ansari, Rafat H., Salim, Muhammed, van der Westhuizen, Andre, Abdi, Ehtesham, Francis, Prudence A., Chia, Stephen, Harvey, Vernon J., Giobbie-Hurder, Anita, Fleming, Gini F., Pagani, Olivia, Di Leo, Angelo, Colleoni, Marco, Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Regan, Meredith M., Bernhard, Jürg
Published in Breast cancer research and treatment (01.06.2020)
Published in Breast cancer research and treatment (01.06.2020)
Get full text
Journal Article
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial
Rabaglio, Manuela, Sun, Zhuoxin, Maibach, Rudolf, Giobbie-Hurder, Anita, Ejlertsen, Bent, Harvey, Vernon J., Neven, Patrick, Láng, István, Bonnefoi, Hervé, Wardley, Andrew, Ruepp, Barbara, Castiglione, Monica, Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Colleoni, Marco, Thürlimann, Beat, Regan, Meredith M.
Published in Breast cancer research and treatment (01.02.2021)
Published in Breast cancer research and treatment (01.02.2021)
Get full text
Journal Article
Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial
Leone, Jose P., Cole, Bernard F., Regan, Meredith M., Thürlimann, Beat, Coates, Alan S., Rabaglio, Manuela, Giobbie‐Hurder, Anita, Gelber, Richard D., Ejlertsen, Bent, Harvey, Vernon J., Neven, Patrick, Láng, Istvan, Bonnefoi, Herve, Wardley, Andrew, Goldhirsch, Aron, Di Leo, Angelo, Colleoni, Marco, Vaz‐Luis, Ines, Lin, Nancy U.
Published in Cancer (01.03.2021)
Published in Cancer (01.03.2021)
Get full text
Journal Article
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial
Leyland-Jones, Brian, Gray, Kathryn P., Abramovitz, Mark, Bouzyk, Mark, Young, Brandon, Long, Bradley, Kammler, Roswitha, Dell’Orto, Patrizia, Biasi, Maria Olivia, Thürlimann, Beat, Lyng, Maria B., Ditzel, Henrik J., Harvey, Vernon J., Neven, Patrick, Treilleux, Isabelle, Rasmussen, Birgitte Bruun, Maibach, Rudolf, Price, Karen N., Coates, Alan S., Goldhirsch, Aron, Pagani, Olivia, Viale, Giuseppe, Rae, James M., Regan, Meredith M.
Published in Breast cancer research and treatment (01.06.2015)
Published in Breast cancer research and treatment (01.06.2015)
Get full text
Journal Article
SERUM INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 FOLLOWING CHEMOTHERAPY FOR ADVANCED BREAST CANCER
Holdaway, Ian M., Mason, Barbara H., Lethaby, Anne E., Singh, Vijay, Harvey, Vernon J., Thompson, Paul I., Evans, Barrie D.
Published in ANZ journal of surgery (01.11.2003)
Published in ANZ journal of surgery (01.11.2003)
Get full text
Journal Article
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial
Joensuu, Heikki, Fraser, Judith, Wildiers, Hans, Huovinen, Riikka, Auvinen, Päivi, Utriainen, Meri, Villman, Kenneth K, Halonen, Päivi, Granstam-Björneklett, Helena, Tanner, Minna, Sailas, Liisa, Turpeenniemi-Hujanen, Taina, Yachnin, Jeffrey, Huttunen, Teppo, Neven, Patrick, Canney, Peter, Harvey, Vernon J, Kellokumpu-Lehtinen, Pirkko-Liisa, Lindman, Henrik
Published in JAMA network open (01.08.2024)
Published in JAMA network open (01.08.2024)
Get full text
Journal Article
Abstract GS3-04: A randomized phase III study of adjuvant trastuzumab for a duration of 9 weeks versus 1 year, combined with adjuvant taxane-anthracycline chemotherapy, for early HER2-positive breast cancer (the SOLD study)
Joensuu, H, Fraser, J, Wildiers, H, Huovinen, R, Auvinen, P, Utriainen, M, Nyandoto, P, Villman, KK, Halonen, P, Granstam-Björneklett, H, Lundgren, L, Yachnin, J, Turpeenniemi-Hujanen, T, Ritchie, D, Huttunen, T, Neven, P, Canney, P, Harvey, VJ, Kellokumpu-Lehtinen, P-L, Lindman, H
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Neratinib after adjuvant chemotherapy and trastuzumab in HER2-positive early breast cancer: Primary analysis at 2 years of a phase 3, randomized, placebo-controlled trial (ExteNET)
Chan, Arlene, Delaloge, Suzette, Holmes, Frankie Ann, Moy, Beverly, Iwata, Hiroji, Harvey, Vernon J., Robert, Nicholas J., Silovski, Tajana, Gokmen, Erhan, Von Minckwitz, Gunter, Ejlertsen, Bent, Chia, Stephen K. L., Mansi, Janine, Barrios, Carlos H., Gnant, Michael, Wong, Alvin, Bryce, Richard, Yao, Bin, Martin, Miguel
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Lack of efficacy of adjuvant lapatinib in HER2-negative breast cancer (HER2–ve BC): Analysis of patients in the TEACH trial
Chavarri Guerra, Yanin, Chan, Arlene, Finkelstein, Dianne M., Chan, Valorie F., Harvey, Vernon J., Lee, Keun Seok, Jain, Minish Mahendra, Petrakova, Katarina, Raina, Vinod, Xu, Binghe, Gomez, Henry, Rappold, Erica, Kaneko, Tomomi, Huang, Yingjie, Goss, Paul E.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Subjective cognitive complaints one year after ceasing adjuvant endocrine therapy for early-stage breast cancer: Findings from the Breast International Group (BIG) 1-98 trial
Phillips, Kelly-Anne, Ribi, Karin, Aldridge, Julie, Thompson, Alastair Mark, Harvey, Vernon J., Thurlimann, Beat J. K., Cardoso, Fatima, Pagani, Olivia, Coates, Alan Stuart, Goldhirsch, Aron, Price, Karen N., Gelber, Richard D., Bernhard, Juerg
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Do men undergoing sterilizing cancer treatments have a fertile future?
Naysmith, T E, Blake, D A, Harvey, V J, Johnson, N P
Published in Human reproduction (Oxford) (01.11.1998)
Published in Human reproduction (Oxford) (01.11.1998)
Get full text
Journal Article